JPS642586A - Western subtype dna and rna molecule of fsme-virus, polypeptide coded by the molecule and its usage - Google Patents

Western subtype dna and rna molecule of fsme-virus, polypeptide coded by the molecule and its usage

Info

Publication number
JPS642586A
JPS642586A JP63067987A JP6798788A JPS642586A JP S642586 A JPS642586 A JP S642586A JP 63067987 A JP63067987 A JP 63067987A JP 6798788 A JP6798788 A JP 6798788A JP S642586 A JPS642586 A JP S642586A
Authority
JP
Japan
Prior art keywords
dna
virus
molecule
fsme
dna molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63067987A
Other languages
English (en)
Japanese (ja)
Other versions
JPH012586A (ja
Inventor
Franz Xaver Heinz
Christian Kunz
Christian Mandl
Friedrich Dorner
Walter Bodemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88103003A external-priority patent/EP0284791B1/de
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of JPH012586A publication Critical patent/JPH012586A/ja
Publication of JPS642586A publication Critical patent/JPS642586A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP63067987A 1987-03-20 1988-03-22 Western subtype dna and rna molecule of fsme-virus, polypeptide coded by the molecule and its usage Pending JPS642586A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP87104114.1 1987-03-20
EP87104114 1987-03-20
EP88103003A EP0284791B1 (de) 1987-03-20 1988-02-29 DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung
EP88103003.5 1988-02-29

Publications (2)

Publication Number Publication Date
JPH012586A JPH012586A (ja) 1989-01-06
JPS642586A true JPS642586A (en) 1989-01-06

Family

ID=26107821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63067987A Pending JPS642586A (en) 1987-03-20 1988-03-22 Western subtype dna and rna molecule of fsme-virus, polypeptide coded by the molecule and its usage

Country Status (4)

Country Link
JP (1) JPS642586A (da)
AT (1) AT398782B (da)
DK (1) DK175515B1 (da)
FI (1) FI98466C (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007300039A (ja) * 2006-05-08 2007-11-15 Matsushita Electric Ind Co Ltd 高電圧トランス

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007300039A (ja) * 2006-05-08 2007-11-15 Matsushita Electric Ind Co Ltd 高電圧トランス

Also Published As

Publication number Publication date
FI98466B (fi) 1997-03-14
FI881294A0 (fi) 1988-03-18
DK149488D0 (da) 1988-03-18
FI881294L (fi) 1988-09-21
AT398782B (de) 1995-01-25
DK149488A (da) 1988-09-21
DK175515B1 (da) 2004-11-15
FI98466C (fi) 1997-06-25
ATA71388A (de) 1994-06-15

Similar Documents

Publication Publication Date Title
DK84194A (da) Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
RU94024561A (ru) Иммунореактивные композиции, способ получения композиции, способы получения и обнаружения антител, набор днк, клетка-хозяин, способ получения белка
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
ATE61228T1 (de) Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff.
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
LU91049I2 (fr) Protéines recombinantes de virus associées avec lesyndrome lymphadénopathique et/ou le syndrome d'i mmuno-déficience acquise (sida)
DE69030124D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
AU571128B2 (en) Expression of immunologically reactive aids viral protein
FI875427A0 (fi) Menetelmä valmistaa hevosen -interferonia
IE811049L (en) Cloned fmdv antigens
NO881904L (no) Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
GR3007909T3 (da)
EP0197772A3 (en) Peptides useful in vaccination against enteroviruses
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
DE3786870D1 (de) Methode zur herstellung von proteinen.
HU903490D0 (en) Process for the preparation of proteins, vaccines and nucleic acid
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
KR890006250A (ko) 재조합 htlv-ⅲ단백질 및 이의 용도
MX9709271A (es) Diagnostico de, y vacunacion contra, en virus de arn de hilo positivo usando un polipeptido aislado, no procesado.
JPS5210492A (en) Preparation of xanthane gum
FR2596771B1 (fr) Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus